Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kaiser Permanente Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 110
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 63
Rounds per year 1.39
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Exits 27
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Software
Summary

Kaiser Permanente Ventures appeared to be the VC, which was created in 1945. The main department of described VC is located in the Oakland. The company was established in North America in United States. Kaiser Permanente Ventures appeared to be a CVC structure as part of the corporation.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Kaiser Permanente Ventures, startups are often financed by New Enterprise Associates, Delphi Ventures, Rock Health. The meaningful sponsors for the fund in investment in the same round are QuestMark Partners, New Leaf Venture Partners, MPM Capital. In the next rounds fund is usually obtained by Norwest Venture Partners, Morgenthaler Ventures, QuestMark Partners.

The fund is generally included in 2-6 deals every year. The average startup value when the investment from Kaiser Permanente Ventures is 500 millions - 1 billion dollars. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2012. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. This Kaiser Permanente Ventures works on 1 percentage points more the average amount of lead investments comparing to the other organizations.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Health Catalyst, Proteus Digital Health, Omada Health Among the most popular fund investment industries, there are Medical Device, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

Besides them, we counted 4 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kaiser Permanente Ventures:
Typical Co-investors
Kaiser Permanente Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kaiser Permanente Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Abridge

Health Care
Medical
Software
$150M23 Feb 2024 Pittsburgh, Pennsylvania, United States

Everytable

Food and Beverage
$25M27 Jun 2023 Los Angeles, California, United States

DexCare

Health Care
Hospital
Software
$75M21 Jun 2023 Seattle, Washington, United States

NOCD

Health Care
Therapeutics
Wellness
$34M31 Jan 2023 Chicago, Illinois, United States

NorthOne

Banking
Financial Services
FinTech
$67M13 Oct 2022 New York, New York, United States

Kate Farms

Food and Beverage
Health Care
Nutrition
$75M19 Sep 2022 Santa Barbara, California, United States

Everytable

Food and Beverage
$55M04 Aug 2022 Los Angeles, California, United States

Ordr

Artificial Intelligence
Cloud Computing
Cyber Security
Internet
Internet of Things
Machine Learning
Network Security
Software
$40M01 Jun 2022 San Jose, California, United States

IntelyCare

Apps
Health Care
Medical
Software
Staffing Agency
$115M06 Apr 2022 Quincy, Massachusetts, United States
News
Osso VR Raises $27M Series B

– Osso VR, a validated virtual reality (VR) surgical training and assessment platform, has secured $27M in Series B funding.
GSR Ventures led the funding round with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures and Anorak Ventures.
– Osso VR’s surgical training technology provides on-demand, educational experiences that are effective, repeatable and measurable to help surgeons reach proficiency with emerging surgical techniques and technologies.

Ginger Announces $100 Million Series E Financing from Blackstone to Bring Value-Based Mental Healthcare to Millions of Employees and Health Plan Members

– Ginger, the on-demand mental health company, announced a $100m Series E financing round led by funds managed by Blackstone Growth.
– The round was led by Blackstone Growth and includes existing investors from Kaiser Permanente Ventures, Cigna Ventures, Bessemer Venture Partners, Advance Ventures Partners, Khosla Ventures, Health Velocity Capital, City Light Capital, and WP Global Partners.
– This latest round of investment will bring the company’s total funding to over $220m on the heels of approximately 3x revenue growth over the past year.
– Over 10m people have access to Ginger in over 40 countries around the world through the company’s partnerships with innovative employers, health plans, and strategic partners.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kaiser Permanente Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 110
Average round size 32M
Rounds per year 1.39
Peak activity year 2012
Lead investments 7
Follow on index 0.43
Exits 27
Group Appearance index 0.99

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Abridge

Health Care
Medical
Software
$150M23 Feb 2024 Pittsburgh, Pennsylvania, United States

Everytable

Food and Beverage
$25M27 Jun 2023 Los Angeles, California, United States

DexCare

Health Care
Hospital
Software
$75M21 Jun 2023 Seattle, Washington, United States

NOCD

Health Care
Therapeutics
Wellness
$34M31 Jan 2023 Chicago, Illinois, United States

NorthOne

Banking
Financial Services
FinTech
$67M13 Oct 2022 New York, New York, United States

Kate Farms

Food and Beverage
Health Care
Nutrition
$75M19 Sep 2022 Santa Barbara, California, United States

Everytable

Food and Beverage
$55M04 Aug 2022 Los Angeles, California, United States

Ordr

Artificial Intelligence
Cloud Computing
Cyber Security
Internet
Internet of Things
Machine Learning
Network Security
Software
$40M01 Jun 2022 San Jose, California, United States

IntelyCare

Apps
Health Care
Medical
Software
Staffing Agency
$115M06 Apr 2022 Quincy, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: